Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00891124
NCT00891124
Completed
Not Applicable

A Multi-center, Prospective, Observational Study to Assess the Effect of Patient Education Related to CV Risk Factors in Type 2 Diabetes Mellitus

AstraZeneca2 sites in 1 country4,045 target enrollmentMay 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGlycemiaHypertensionHyperlipidemia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glycemia
Sponsor
AstraZeneca
Enrollment
4045
Locations
2
Primary Endpoint
Proportion of achievement patients in treatment target goal on glycemic control, hypertension and hyperlipidemia according to ADA 2008 guideline
Status
Completed
Last Updated
16 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This study will address the proportion of achievement patients in treatment target goal on glycemic control, hypertension and hyperlipidemia according to ADA 2008 guideline, among outpatients coming to the Korean primary care nationwide.

Registry
clinicaltrials.gov
Start Date
May 2009
End Date
October 2009
Last Updated
16 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients who had been diagnosed with type II diabetes mellitus
  • •Patients with hypertension and / or hyperlipidemia
  • •Patients who had agreed to Informed

Exclusion Criteria

  • •Patients who had been diagnosed with type I diabetes mellitus
  • •Patients with neither hypertension and hyperlipidemia

Outcomes

Primary Outcomes

Proportion of achievement patients in treatment target goal on glycemic control, hypertension and hyperlipidemia according to ADA 2008 guideline

Time Frame: At baseline and Endpiont (after 2months)

Secondary Outcomes

  • The treatment goal of risk factors is based on ADA guideline.(At baseline and Endpiont (after 2months))

Study Sites (2)

Loading locations...

Similar Trials

Completed
Phase 3
Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)Diabetes Mellitus, Type 2
NCT00653341Sanofi764
Completed
Phase 4
Comparison Between Levofloxacin and Prulifloxacin, in Internal Medicine Patients With Acute Exacerbation of COPDCOPD Exacerbation
NCT01710488Fadoi Foundation, Italy258
Terminated
Phase 2
Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute PancreatitisHypertriglyceridemia
NCT04863014Regeneron Pharmaceuticals21
Completed
Not Applicable
Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot UlcersDiabetic Foot Ulcer
NCT01693133MiMedx Group, Inc.132
Completed
Not Applicable
Retrospective Study of Glucose Monitoring for Glycemic Control in Patients With GSDIaGlycogen Storage Disease Type IA
NCT04708015Ultragenyx Pharmaceutical Inc15